In fact, we found that after knocking down AURKC in ccRCC or following treatment with a phosphokinase inhibitor, the expression level of ERp57 was significantly downregulated, and the distribution of ERp57 in the nucleus also decreased, providing evidence in support of our hypothesis. This evidence concerns the gene AURKC and nonpapillary renal cell carcinoma.